About Vakzine Projekt Management
VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. The company was established in 2002 following an initiative of the German Federal Ministry of Education and Research to promote the German market by funding vaccine development.
Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs from academic research and brought them into clinical phase I and II trials.More about us
News & Press
VPM will be present at the "Successful R&I in Europe 2019: 10th European Networking Event" which will take place in Düsseldorf on 14-15 February, 2019.
VPM will speak during a Rebirth special lecture, that will take place in the Hannover Medical School (Lecture Hall M,I1) on 12. February 2019, 5:00 pm.
VPM was invited to join the TBVI (TuBerculosis Vaccine Initiative) Annual Symposium which was held on 29th of January until 31th of January 2019 in Les Diablerets, Switzerland.